Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Novavax Inc (NQ: NVAX )

91.25 USD +0.09 (+0.10%)
Streaming Delayed Price Updated: 4:16 AM EDT, Oct 22, 2020 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Stories about Novavax Inc

< Previous 1 2 3 4 5 6 7 8 9
...
64 65 Next >
Notable ETF Outflow Detected - IWN, DAR, NVAX, PFGC
Symbols mentioned in this story: IWN, DAR, NVAX, PFGC Exchange traded funds (ETFs) trade just like stocks, but instead of ''shares'' investors are actually buying and selling ''units''. These ''units''... 
Tags ETFs
From ETF Channel
Notable Tuesday Option Activity: MLHR, NVAX, STZ
Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in Miller (Herman) Inc (MLHR), where a total volume of 4,443 contracts has been traded... 
Tags Stocks
From Market News Video
Big Pharma's Vaccine Race – A Chance For Redemption
The whole world is coming together in the fight against COVID-19. The quest for a vaccine is revolutionizing the controversial Big ... 
Tags Biotech SNY PFE
From Benzinga
Why one research firm says it’s time to start shorting overextended markets
To analysts at Longview Economics, a London-based research firm, it's looking like the rally from September lows was overextended, and the upside trend is "tired." They say markets are overbought at an... 
Tags TWTR XE:HFG MDRX
From MarketWatch
60 Biggest Movers From Yesterday
Gainers Medigus Ltd. (NASDAQ: MDGS) shares jumped 52.9% to close at $2.89 on Tuesday after the company announced it was informed ... 
Tags Movers MDGS Penny Stocks
From Benzinga
World Bank Approves $12B Financing To Ensure Developing Countries Aren't Deprived Of COVID-19 Vaccine
The World Bank said Monday that its Board of Executive Directors has approved$12 billion in financing for developing countries to ... 
Tags Global SNY Covid/19
From Benzinga
Novavax To Evaluate Flu-COVID-19 Vaccine Combo
Novavax, Inc. (NASDAQ: NVAX) shares were advancing strongly Tuesday after the coronavirus vaccine developer announced updates on its ... 
Tags vaccine Biotech Coronavirus
From Benzinga
46 Stocks Moving In Tuesday's Mid-Day Session
Gainers Medigus Ltd. (NASDAQ: MDGS) shares climbed 57.2% to $2.97 after the company announced it was informed by Smart Repair Pro ... 
Tags ETH WAFU SOL
From Benzinga
Novavax Sets Up Team To Explore A Combination Covid-19/Flu Vaccine Post-Pandemic
Novavax on Tuesday named a team of executives to lead the exploration of a possible Covid-19/flu combo vaccine, for after the pandemic, as it continues late-stage trials on its Covid vaccine. 
From Investor's Business Daily
Are These The Best Biotech Stocks To Watch This Week?
From Stockmarket.com
Johnson & Johnson Pauses Covid-19 Vaccine Tests; Raises Earnings Guidance
Johnson & Johnson paused key final-phase testing of its Covid-19 vaccine candidate, but then beat third-quarter earnings views. JNJ stock fell. 
From Investor's Business Daily
How The Parts Add Up: XBI Headed For $174
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
Is Novavax Stock Too Risky to Buy Today?
The stock has soared by 2,700% so far this year. Is it still worth investing in today? 
Tags JNJ Market News AZN
From Motley Fool
Why Is Everyone Talking About Inovio Stock?
This popular coronavirus vaccine developer stock is down 61% from all-time highs, and the bottom has yet to arrive. 
Tags INO JNJ MRNA
From Motley Fool
3 Stocks to Buy No Matter What Happens in November
Forget politics and a pandemic. The outlook for these stocks keeps getting better, and analysts can't keep up. 
Tags EBS VXRT JNJ
From Motley Fool
Could Inovio Pharmaceuticals Be a Millionaire-Maker Stock?
Much still rests on the fate of Inovio's halted coronavirus vaccine trial. 
Tags INO MRNA Market News
From Motley Fool
Better Coronavirus Stock: Johnson & Johnson vs. Novavax
These COVID-19 vaccine leaders offer very different risk-reward propositions. 
Tags NVAX Market News JNJ
From Motley Fool
Notable Friday Option Activity: NVAX, MS, MDC
Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in Novavax, Inc. (NVAX), where a total volume of 19,501 contracts has been traded thus... 
Tags Stocks
From Market News Video
Are These The Top Medical Stocks To Watch In 2020?
From Stockmarket.com
2 Healthcare Stocks That Could Soar in 2020
But are they likely to outperform in the long run? 
Tags VXRT NVAX Market News
From Motley Fool
3 Popular Robinhood Stocks That Could Realistically Double Within 1 Year
Here's what it would take. 
Tags CGC NVAX Market News
From Motley Fool
Moderna, Pfizer Have 2-Month Lead Over Coronavirus Vaccine Competitors: Analyst
The coronavirus vaccine race hastwo likely winners that have surged ahead in a crowded field, according to an SVB Leerink ... 
Tags JNJ Geoffrey Porges Analyst Color
From Benzinga
Bill Gates Says Regulatory Approval For Antibody Drugs Could Sharply Reduce COVID-19 Mortality
Antibody drugs currently undergoing testing could be a panacea for the COVID-19 pandemic ravaging the world once they get regulatory ... 
Tags Media MSFT NVAX
From Benzinga
COVID-19 Vaccine Developer Novavax In Spotlight As Insiders Offload Shares
Novavax, Inc. (NASDAQ: NVAX) shares, which peaked at $189.40 in early August, gave back some of their gains through August and early ... 
Tags Benzinga Insider Trades News
From Benzinga
Pfizer, BioNTech Start Approval Process For Covid-19 Vaccine Candidate In Europe
BioNTech and partner Pfizer announced the start of a rolling submission process for the approval of their Covid-19 vaccine candidate in Europe. 
From Investor's Business Daily
Pfizer, BioNTech Start Approval Process For Covid-19 Vaccine Candidate In Europe
BioNTech and partner Pfizer announced the start of a rolling submission process for the approval of their Covid-19 vaccine candidate in Europe. 
From Investor's Business Daily
Pfizer, BioNTech Start Approval Process For Covid-19 Vaccine Candidate In Europe
BioNTech and partner Pfizer announced the start of a rolling submission process for the approval of their Covid-19 vaccine candidate in Europe. 
From Investor's Business Daily
Why Is Everyone Talking About Novavax Stock?
The vaccine specialist is squarely in the COVID-19 discussion. 
Tags NVAX AZN Market News
From Motley Fool
COVID-19 Vaccine Makers AstraZeneca, GSK To Get First Access To Nvidia's 'Cambridge-1' Supercomputer
Nvidia Corporation (NASDAQ: NVDA) said Monday it is working to build the United Kingdom’s most powerful supercomputer, which it ... 
Tags Health Care Cambridge/1 Tech
From Benzinga
Doubling Down On China's COVID-19 Bio-Tech Disrupters
Looking for Alpha Undervalued Bio-Tech COVID-19 Disrupters. 
Tags Stocks / Equities Healthcare
From Blogs - TalkMarkets
< Previous 1 2 3 4 5 6 7 8 9
...
64 65 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.